Is C-reactive protein an innocent bystander or proatherogenic culprit? - The verdict is still out

被引：153

作者：

Scirica, BM

Morrow, DA

机构：

[1] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Dept Med, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada

[4] Univ Calif Davis, Lab Artherosclerosis & Metab Res, Dept Med Pathol & Lab Med, Med Ctr, Sacramento, CA 95817 USA

[5] Univ Calif Davis, Div Endocrinol Clin Nutr & Vasc Med, Dept Med, Med Ctr, Sacramento, CA 95817 USA

来源：

CIRCULATION | 2006年 / 113卷 / 17期

关键词：

D O I：

10.1161/CIRCULATIONAHA.105.611350

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2128 / 2134

页数：7

共 54 条

[1] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[2] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[3] Effects of statins on nonlipid serum markers associated with cardiovascular disease - A systematic review [J].

Balk, EM ;

Lau, J ;

Goudas, LC ;

Jordan, HS ;

Kupelnick, B ;

Kim, LU ;

Karas, RH .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (08) :670-682

[4] ELEVATION OF C-REACTIVE PROTEIN IN ACTIVE CORONARY-ARTERY DISEASE [J].

BERK, BC ;

WEINTRAUB, WS ;

ALEXANDER, RW .

AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03) :168-172

[5] Activation of inflammation and coagulation after infusion of C-reactive protein in humans [J].

Bisoendial, RJ ;

Kastelein, JJP ;

Levels, JHM ;

Zwaginga, JJ ;

van den Bogaard, B ;

Reitsma, PH ;

Meijers, JCM ;

Hartman, D ;

Levi, M ;

Stroes, ESG .

CIRCULATION RESEARCH, 2005, 96 (07) :714-716

[6] Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Grayston, JT ;

Muhlestein, B ;

Giugliano, RP ;

Cairns, R ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) :1646-1654

[7] C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids [J].

Chang, MK ;

Binder, CJ ;

Torzewski, M ;

Witztum, JL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :13043-13048

[8] C-reactive protein and the 10-year incidence of coronary heart disease in older men and women - The cardiovascular health study [J].

Cushman, M ;

Arnold, AM ;

Psaty, BM ;

Manolio, TA ;

Kuller, LH ;

Burke, GL ;

Polak, JF ;

Tracy, RP .

CIRCULATION, 2005, 112 (01) :25-31

[9] Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].

Danesh, J ;

Collins, R ;

Appleby, P ;

Peto, R .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482

[10] C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].

Danesh, J ;

Wheeler, JG ;

Hirschfield, GM ;

Eda, S ;

Eiriksdottir, G ;

Rumley, A ;

Lowe, GDO ;

Pepys, MB ;

Gudnason, V .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397

← 1 2 3 4 5 6 →